Abacavir and Lamivudine Tablets and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Abacavir and Lamivudine Tablets and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / lamivudine
Brand name: Epzicom
Synonyms: Abacavir and lamivudine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir and Lamivudine Tablets-Insulin degludec
- Abacavir and Lamivudine Tablets-Insulin Degludec (U-100) Prefilled Pens
- Abacavir and Lamivudine Tablets-Insulin Degludec (U-100) Vials
- Abacavir and Lamivudine Tablets-Insulin Degludec (U-200) Prefilled Pens
- Abacavir and Lamivudine Tablets-Insulin degludec and liraglutide
- Abacavir and Lamivudine Tablets-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Abacavir Oral Solution
- Insulin aspart, recombinant Subcutaneous-Abacavir Sulfate
- Insulin aspart, recombinant Subcutaneous-Abacavir Sulfate Tablets
- Insulin aspart, recombinant Subcutaneous-Abacavir Tablets
- Insulin aspart, recombinant Subcutaneous-Abacavir, dolutegravir, and lamivudine
- Insulin aspart, recombinant Subcutaneous-Abacavir, Lamivudine and Zidovudine Tablets